Related Experiment Video

Updated: Jul 12, 2026

Quantitative Assessment of Cortical Auditory-tactile Processing in Children with Disabilities
09:38

Quantitative Assessment of Cortical Auditory-tactile Processing in Children with Disabilities

Published on: January 29, 2014

11.4K

Test development in the pediatric multiphasic program

C M Allen1, J R Metz, H R Shinefield

  • 1Department of Pediatrics, The Permanente Medical Group, San Francisco, USA.

Pediatric Clinics of North America
|April 15, 2015
PubMed

Insights

Multiphasic screening tests in children are crucial for early detection. These tests identify chronic complications, contributing abnormalities, and insidious conditions, enabling timely intervention for better health outcomes.

Area of Science:

  • Pediatric Medicine
  • Public Health
  • Screening Programs

Background:

  • Acute childhood conditions can lead to chronic complications.
  • Undiagnosed abnormalities may predispose children to acute health issues.
  • Certain chronic conditions benefit significantly from early detection and intervention.

Purpose of the Study:

  • To outline the critical areas necessitating multiphasic screening in pediatric populations.
  • To emphasize the role of screening in preventing long-term health problems.
  • To highlight the importance of early intervention strategies.

Main Methods:

  • Review of existing pediatric health data.
  • Analysis of common acute and chronic childhood conditions.
  • Identification of key screening indicators.

Main Results:

  • Screening effectively detects chronic complications from acute illnesses.
  • Abnormalities predisposing to acute conditions are identifiable through screening.
  • Early identification of insidious chronic conditions is feasible.

Conclusions:

  • Multiphasic screening is essential for comprehensive pediatric care.
  • Screening facilitates proactive management of childhood health.
  • Early intervention based on screening improves long-term pediatric health outcomes.

More Related Videos

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder09:13

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder

Published on: April 22, 2015

17.3K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

2.2K

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...